{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T19:56:57Z","timestamp":1767988617134,"version":"3.49.0"},"reference-count":16,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":572,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:p>Objective. To evaluate the influence of pre\u2010transplant recipient sensitization on the outcome of 1\u2010haploidentical live related donor (LRD) kidney transplants. \u2028Method. We reviewed 141 consecutive cyclosporine\u2010treated adult haploidentical first transplants for which panel reactive antibody (PRA) levels were available. Patients were divided into three groups according to their peak PRA levels: group I, PRA=0 (n=97); group II, PRA =1\u201350% (n=24); and group III, PRA=51\u2013100% (n=20). \u2028Results. Differences in PRA were associated with significant differences in short\u2010 and longer\u2010term graft survival, unrelated to patient survival. Graft survival at 1, 3, and 5 yr was only 74, 40, and 27% in group III, compared to 92, 87, and 52% in group II, and 96, 91, and 85% in group I (p&lt;0.001). Increasing PRA was associated with shorter time\u2010to\u2010graft failure. In group III, 20% lost their transplant from acute rejection in the first 6 months, versus 4% in group II and 3% in group I (p&lt;0.01). Graft survival in group II diverged from that of group I only after 3 yr, due to an increase in loss from chronic rejection. Hospitalization was longer in group III, in association with a significantly higher incidence of acute rejection during the first 3 months after transplantation (p&lt;0.02). Serum creatinine was higher in sensitized than nonsensitized patients at all time points. \u2028Conclusions. Sensitization has a significant negative impact on the outcome of haploidentical LRD kidney transplants. Sensitized potential recipients and their potential donors should be aware of this in arriving at informed decision\u2010making for transplantation. These patients may benefit from more sensitive cross\u2010match testing, more intense or more novel immunosuppression, or immunomodulation to modify their immune responsiveness.<\/jats:p>","DOI":"10.1034\/j.1399-0012.2000.140306.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T13:46:06Z","timestamp":1047390366000},"page":"212-217","source":"Crossref","is-referenced-by-count":36,"title":["Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants"],"prefix":"10.1111","volume":"14","author":[{"given":"A","family":"Barama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Oza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Panek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Belitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"As","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lawen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Kiberd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"433","article-title":"Histocompatibility matching utilizing responsiveness as a new dimension","volume":"4","author":"Opelz G","year":"1972","journal-title":"Transplant Proc"},{"key":"e_1_2_6_3_2","first-page":"553","volume-title":"Clinical Transplants","author":"Terasaki PI","year":"1993"},{"key":"e_1_2_6_4_2","first-page":"463","article-title":"Use of an antiglobuline\u2010ATG reagent for detection of low levels of alloantibody \u2013 improvement of allograft survival in presensitized recipients","volume":"10","author":"Fuller TC","year":"1978","journal-title":"Transplant Proc"},{"key":"e_1_2_6_5_2","first-page":"313","volume-title":"Clinical Transplants","author":"Zhou YC","year":"1991"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199102000-00016"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1993.tb00636.x"},{"key":"e_1_2_6_8_2","first-page":"771","article-title":"Influence of pretransplant antibodies one early renal allograft rejection","volume":"19","author":"Alarif L","year":"1987","journal-title":"Transpl Proc"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199403270-00033"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199003000-00011"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0966-3274(93)90035-7"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199502270-00032"},{"key":"e_1_2_6_13_2","first-page":"2480","article-title":"Analysis of flow cytometry and cytotoxicity crossmatches in renal transplantation","volume":"17","author":"Chapman JR","year":"1985","journal-title":"Transplant Proc"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199308000-00007"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199001000-00011"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199102000-00008"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198207000-00005"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2000.140306.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1399-0012.2000.140306.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1399-0012.2000.140306.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T14:31:15Z","timestamp":1698589875000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1399-0012.2000.140306.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1034\/j.1399-0012.2000.140306.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1399-0012.2000.140306.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}